It is a pleasure to announce the upcoming Action webinar entitled "FDA Guidance: Drug Products Containing Nanomaterial" proferred by Dr. Anil Patri, an authority in the field.
The webinar will be held on November 2nd at 8:30 am US EST.
Dr. Patri will focus his lecture on overarching guidance that applies to all products containing nanomaterial and the draft guidance specific to drug products and biologics. In the process, he will bring up factors to consider when one develops a product through pre-clinical testing.
More info, details, and registration for the webinar will be available soon.
A short bio of Dr. Patri can be downloaded from this page.
You are invited to attend!